Click here to get full coverage on Brookstone Capital Management Grows Stock Holdings in Harrow, Inc. $HROW - MarketBeat

Brookstone Capital Management Grows Stock Holdings in Harrow, Inc. $HROW  MarketBeat

Brookstone Capital Management Grows Stock Holdings in Harrow, Inc. $HROW - MarketBeat

Click here to get full coverage on How CVS Elevating Vevye To Tier 1 Coverage At Harrow (HROW) Has Changed Its Investment Story - Yahoo Finance

How CVS Elevating Vevye To Tier 1 Coverage At Harrow (HROW) Has Changed Its Investment Story  Yahoo Finance

How CVS Elevating Vevye To Tier 1 Coverage At Harrow (HROW) Has Changed Its Investment Story - Yahoo Finance

Click here to get full coverage on First Week of February 2026 Options Trading For Harrow (HROW) - Nasdaq

First Week of February 2026 Options Trading For Harrow (HROW)  Nasdaq

First Week of February 2026 Options Trading For Harrow (HROW) - Nasdaq

Click here to get full coverage on Harrow (NASDAQ:HROW) Has A Somewhat Strained Balance Sheet - 富途牛牛

Harrow (NASDAQ:HROW) Has A Somewhat Strained Balance Sheet  富途牛牛

Harrow (NASDAQ:HROW) Has A Somewhat Strained Balance Sheet - 富途牛牛

Click here to get full coverage on Harrow Q3 Earnings Preview: This Business Has Eye-Popping Potential (NASDAQ:HROW) - Seeking Alpha

Harrow Q3 Earnings Preview: This Business Has Eye-Popping Potential (NASDAQ:HROW)  Seeking Alpha

Harrow Q3 Earnings Preview: This Business Has Eye-Popping Potential (NASDAQ:HROW) - Seeking Alpha

Click here to get full coverage on Harrow (HROW): Assessing Valuation After a 29% One-Month Share Price Surge - simplywall.st

Harrow (HROW): Assessing Valuation After a 29% One-Month Share Price Surge  simplywall.st

Harrow (HROW): Assessing Valuation After a 29% One-Month Share Price Surge - simplywall.st

Click here to get full coverage on $HROW stock is down 8% today. Here's what we see in our data. - Quiver Quantitative

$HROW stock is down 8% today. Here's what we see in our data.  Quiver Quantitative

$HROW stock is down 8% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Harrow, Inc. $HROW Shares Sold by Rice Hall James & Associates LLC - MarketBeat

Harrow, Inc. $HROW Shares Sold by Rice Hall James & Associates LLC  MarketBeat

Harrow, Inc. $HROW Shares Sold by Rice Hall James & Associates LLC - MarketBeat

Click here to get full coverage on Harrow (HROW) Is Up After Q3 Profit Turnaround and Revenue Growth Are Reported – What's Changed - Yahoo Finance

Harrow (HROW) Is Up After Q3 Profit Turnaround and Revenue Growth Are Reported – What's Changed  Yahoo Finance

Harrow (HROW) Is Up After Q3 Profit Turnaround and Revenue Growth Are Reported – What's Changed - Yahoo Finance

Click here to get full coverage on Harrow (NASDAQ:HROW) Hits New 1-Year High - Time to Buy? - MarketBeat

Harrow (NASDAQ:HROW) Hits New 1-Year High - Time to Buy?  MarketBeat

Harrow (NASDAQ:HROW) Hits New 1-Year High - Time to Buy? - MarketBeat

Click here to get full coverage on Harrow Inc (HROW) Q3 2025 Earnings Call Highlights: Revenue Surge and Strategic Growth Plans - Yahoo Finance

Harrow Inc (HROW) Q3 2025 Earnings Call Highlights: Revenue Surge and Strategic Growth Plans  Yahoo Finance

Harrow Inc (HROW) Q3 2025 Earnings Call Highlights: Revenue Surge and Strategic Growth Plans - Yahoo Finance

Click here to get full coverage on Could Harrow’s (HROW) New Pricing Program Redefine Its Patient Access Advantage? - Yahoo Finance

Could Harrow’s (HROW) New Pricing Program Redefine Its Patient Access Advantage?  Yahoo Finance

Could Harrow’s (HROW) New Pricing Program Redefine Its Patient Access Advantage? - Yahoo Finance

Click here to get full coverage on Surging Earnings Estimates Signal Upside for Harrow (HROW) Stock - Yahoo Finance

Surging Earnings Estimates Signal Upside for Harrow (HROW) Stock  Yahoo Finance

Surging Earnings Estimates Signal Upside for Harrow (HROW) Stock - Yahoo Finance

Click here to get full coverage on Assessing Harrow (HROW) Valuation Following Strong Q3 Growth and New Product Momentum - Yahoo Finance

Assessing Harrow (HROW) Valuation Following Strong Q3 Growth and New Product Momentum  Yahoo Finance

Assessing Harrow (HROW) Valuation Following Strong Q3 Growth and New Product Momentum - Yahoo Finance

Click here to get full coverage on Harrow (HROW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance

Harrow (HROW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release  Yahoo Finance

Harrow (HROW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance

Click here to get full coverage on Harrow, Inc. (HROW): A Bull Case Theory - Yahoo Finance

Harrow, Inc. (HROW): A Bull Case Theory  Yahoo Finance

Harrow, Inc. (HROW): A Bull Case Theory - Yahoo Finance

Click here to get full coverage on A Fresh Look at Harrow (HROW) Valuation Following Recent Revenue Growth and Long-Term Performance - Yahoo Finance

A Fresh Look at Harrow (HROW) Valuation Following Recent Revenue Growth and Long-Term Performance  Yahoo Finance

A Fresh Look at Harrow (HROW) Valuation Following Recent Revenue Growth and Long-Term Performance - Yahoo Finance

Click here to get full coverage on Harrow (HROW) Launches US$250M Senior Notes Offering To Refinance Debt - Yahoo Finance

Harrow (HROW) Launches US$250M Senior Notes Offering To Refinance Debt  Yahoo Finance

Harrow (HROW) Launches US$250M Senior Notes Offering To Refinance Debt - Yahoo Finance

Click here to get full coverage on Harrow Inc (HROW) Q2 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance

Harrow Inc (HROW) Q2 2025: Everything You Need To Know Ahead Of Earnings  Yahoo Finance

Harrow Inc (HROW) Q2 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance

Click here to get full coverage on Harrow: Vevye Replaces Xiidra On Tier 1 Formulary At CVS (NASDAQ:HROW) - Seeking Alpha

Harrow: Vevye Replaces Xiidra On Tier 1 Formulary At CVS (NASDAQ:HROW)  Seeking Alpha

Harrow: Vevye Replaces Xiidra On Tier 1 Formulary At CVS (NASDAQ:HROW) - Seeking Alpha

Click here to get full coverage on Harrow (NASDAQ: HROW) to join BTIG Ophthalmology Day and Piper Sandler conference - Stock Titan

Harrow (NASDAQ: HROW) to join BTIG Ophthalmology Day and Piper Sandler conference  Stock Titan

Harrow (NASDAQ: HROW) to join BTIG Ophthalmology Day and Piper Sandler conference - Stock Titan

Click here to get full coverage on Noteworthy Monday Option Activity: SANM, HROW, ASPN - Nasdaq

Noteworthy Monday Option Activity: SANM, HROW, ASPN  Nasdaq

Noteworthy Monday Option Activity: SANM, HROW, ASPN - Nasdaq

Click here to get full coverage on Noteworthy Friday Option Activity: HROW, EWTX, RBLX - Nasdaq

Noteworthy Friday Option Activity: HROW, EWTX, RBLX  Nasdaq

Noteworthy Friday Option Activity: HROW, EWTX, RBLX - Nasdaq

Click here to get full coverage on Frank Mullery named CEO; Bridseida Cruz named Head of Quality at ImprimisRx, Harrow subsidiary - Stock Titan

Frank Mullery named CEO; Bridseida Cruz named Head of Quality at ImprimisRx, Harrow subsidiary  Stock Titan

Frank Mullery named CEO; Bridseida Cruz named Head of Quality at ImprimisRx, Harrow subsidiary - Stock Titan

Click here to get full coverage on Harrow (NASDAQ: HROW) sets third-quarter results Nov 10; call and webcast Nov 11 - Stock Titan

Harrow (NASDAQ: HROW) sets third-quarter results Nov 10; call and webcast Nov 11  Stock Titan

Harrow (NASDAQ: HROW) sets third-quarter results Nov 10; call and webcast Nov 11 - Stock Titan

Click here to get full coverage on New Analyst Forecast: $HROW Given $69.0 Price Target - Quiver Quantitative

New Analyst Forecast: $HROW Given $69.0 Price Target  Quiver Quantitative

New Analyst Forecast: $HROW Given $69.0 Price Target - Quiver Quantitative

Click here to get full coverage on Harrow: Positive And Negative Adjustments After Investor Day Offset Each Other (HROW) - Seeking Alpha

Harrow: Positive And Negative Adjustments After Investor Day Offset Each Other (HROW)  Seeking Alpha

Harrow: Positive And Negative Adjustments After Investor Day Offset Each Other (HROW) - Seeking Alpha

Click here to get full coverage on What To Expect From Harrow Inc (HROW) Q1 2025 Earnings - Yahoo Finance

What To Expect From Harrow Inc (HROW) Q1 2025 Earnings  Yahoo Finance

What To Expect From Harrow Inc (HROW) Q1 2025 Earnings - Yahoo Finance

Click here to get full coverage on B. Riley Securities Reiterates Harrow (HROW) Buy Recommendation - Nasdaq

B. Riley Securities Reiterates Harrow (HROW) Buy Recommendation  Nasdaq

B. Riley Securities Reiterates Harrow (HROW) Buy Recommendation - Nasdaq

Click here to get full coverage on Why (HROW) Price Action Is Critical for Tactical Trading - Stock Traders Daily

Why (HROW) Price Action Is Critical for Tactical Trading  Stock Traders Daily

Why (HROW) Price Action Is Critical for Tactical Trading - Stock Traders Daily

Click here to get full coverage on William Blair Initiates Coverage of Harrow (HROW) With an Outperform Rating - Yahoo Finance

William Blair Initiates Coverage of Harrow (HROW) With an Outperform Rating  Yahoo Finance

William Blair Initiates Coverage of Harrow (HROW) With an Outperform Rating - Yahoo Finance

Click here to get full coverage on Braidwell LP Trims Holdings in Harrow, Inc. $HROW - MarketBeat

Braidwell LP Trims Holdings in Harrow, Inc. $HROW  MarketBeat

Braidwell LP Trims Holdings in Harrow, Inc. $HROW - MarketBeat

Click here to get full coverage on Investors might be losing patience for Harrow's (NASDAQ:HROW) increasing losses, as stock sheds 10% over the past week - Yahoo Finance

Investors might be losing patience for Harrow's (NASDAQ:HROW) increasing losses, as stock sheds 10% over the past week  Yahoo Finance

Investors might be losing patience for Harrow's (NASDAQ:HROW) increasing losses, as stock sheds 10% over the past week - Yahoo Finance

Click here to get full coverage on Harrow (Nasdaq: HROW) Closes Melt Deal, Sets MELT-300 NDA Filing for 2027 in U.S. - Stock Titan

Harrow (Nasdaq: HROW) Closes Melt Deal, Sets MELT-300 NDA Filing for 2027 in U.S.  Stock Titan

Harrow (Nasdaq: HROW) Closes Melt Deal, Sets MELT-300 NDA Filing for 2027 in U.S. - Stock Titan

Click here to get full coverage on $250 Million Debt Offering: Harrow's Major Refinancing Plan Includes New Credit Line and Notes Redemption - Stock Titan

$250 Million Debt Offering: Harrow's Major Refinancing Plan Includes New Credit Line and Notes Redemption  Stock Titan

$250 Million Debt Offering: Harrow's Major Refinancing Plan Includes New Credit Line and Notes Redemption - Stock Titan

Click here to get full coverage on Should Vevye’s CVS Formulary Win Prompt a Closer Look from Harrow (HROW) Investors? - simplywall.st

Should Vevye’s CVS Formulary Win Prompt a Closer Look from Harrow (HROW) Investors?  simplywall.st

Should Vevye’s CVS Formulary Win Prompt a Closer Look from Harrow (HROW) Investors? - simplywall.st

Click here to get full coverage on Harrow Baby Bonds Yield Review (NASDAQ:HROW) - Seeking Alpha

Harrow Baby Bonds Yield Review (NASDAQ:HROW)  Seeking Alpha

Harrow Baby Bonds Yield Review (NASDAQ:HROW) - Seeking Alpha

Click here to get full coverage on Divisadero Street Capital Management LP Takes Position in Harrow, Inc. $HROW - MarketBeat

Divisadero Street Capital Management LP Takes Position in Harrow, Inc. $HROW  MarketBeat

Divisadero Street Capital Management LP Takes Position in Harrow, Inc. $HROW - MarketBeat

Click here to get full coverage on Leading Eyecare Pharma Harrow Sets Q2 Earnings Release: Key Details for Investors - Stock Titan

Leading Eyecare Pharma Harrow Sets Q2 Earnings Release: Key Details for Investors  Stock Titan

Leading Eyecare Pharma Harrow Sets Q2 Earnings Release: Key Details for Investors - Stock Titan

Click here to get full coverage on Harrow, Inc. (HROW) Emerges as Eye Care Powerhouse With Biosimilars to Lucentis and Eylea - Yahoo Finance

Harrow, Inc. (HROW) Emerges as Eye Care Powerhouse With Biosimilars to Lucentis and Eylea  Yahoo Finance

Harrow, Inc. (HROW) Emerges as Eye Care Powerhouse With Biosimilars to Lucentis and Eylea - Yahoo Finance

Click here to get full coverage on 155,465 Shares in Harrow, Inc. $HROW Acquired by Diametric Capital LP - MarketBeat

155,465 Shares in Harrow, Inc. $HROW Acquired by Diametric Capital LP  MarketBeat

155,465 Shares in Harrow, Inc. $HROW Acquired by Diametric Capital LP - MarketBeat

Click here to get full coverage on Harrow (HROW) Stock Jumps 11.4%: Will It Continue to Soar? - Yahoo Finance

Harrow (HROW) Stock Jumps 11.4%: Will It Continue to Soar?  Yahoo Finance

Harrow (HROW) Stock Jumps 11.4%: Will It Continue to Soar? - Yahoo Finance

Click here to get full coverage on Wall Street Analysts Think Harrow (HROW) Could Surge 53.24%: Read This Before Placing a Bet - Yahoo Finance

Wall Street Analysts Think Harrow (HROW) Could Surge 53.24%: Read This Before Placing a Bet  Yahoo Finance

Wall Street Analysts Think Harrow (HROW) Could Surge 53.24%: Read This Before Placing a Bet - Yahoo Finance

Click here to get full coverage on Harrow: Buy A Blend Of Value And Growth (NASDAQ:HROW) - Seeking Alpha

Harrow: Buy A Blend Of Value And Growth (NASDAQ:HROW)  Seeking Alpha

Harrow: Buy A Blend Of Value And Growth (NASDAQ:HROW) - Seeking Alpha

Click here to get full coverage on We Might See A Profit From Harrow, Inc. (NASDAQ:HROW) Soon - Yahoo Finance

We Might See A Profit From Harrow, Inc. (NASDAQ:HROW) Soon  Yahoo Finance

We Might See A Profit From Harrow, Inc. (NASDAQ:HROW) Soon - Yahoo Finance

Click here to get full coverage on Harrow (NASDAQ:HROW) Reaches New 52-Week High - What's Next? - MarketBeat

Harrow (NASDAQ:HROW) Reaches New 52-Week High - What's Next?  MarketBeat

Harrow (NASDAQ:HROW) Reaches New 52-Week High - What's Next? - MarketBeat

Click here to get full coverage on Notable Wednesday Option Activity: HROW, WAY, ATR - Nasdaq

Notable Wednesday Option Activity: HROW, WAY, ATR  Nasdaq

Notable Wednesday Option Activity: HROW, WAY, ATR - Nasdaq

Click here to get full coverage on Panagora Asset Management Inc. Acquires Shares of 47,132 Harrow, Inc. $HROW - MarketBeat

Panagora Asset Management Inc. Acquires Shares of 47,132 Harrow, Inc. $HROW  MarketBeat

Panagora Asset Management Inc. Acquires Shares of 47,132 Harrow, Inc. $HROW - MarketBeat

Click here to get full coverage on Harrow, Inc. $HROW Shares Bought by Marshall Wace LLP - MarketBeat

Harrow, Inc. $HROW Shares Bought by Marshall Wace LLP  MarketBeat

Harrow, Inc. $HROW Shares Bought by Marshall Wace LLP - MarketBeat

Click here to get full coverage on 4 Renowned Eye Disease Experts Join Harrow's Investor Day to Share Vision for Ophthalmic Solutions - Stock Titan

4 Renowned Eye Disease Experts Join Harrow's Investor Day to Share Vision for Ophthalmic Solutions  Stock Titan

4 Renowned Eye Disease Experts Join Harrow's Investor Day to Share Vision for Ophthalmic Solutions - Stock Titan

Click here to get full coverage on Harrow Inc (HROW) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... - Yahoo Finance

Harrow Inc (HROW) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...  Yahoo Finance

Harrow Inc (HROW) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... - Yahoo Finance

Click here to get full coverage on Harrow, Inc. (HROW): A Bull Case Theory - Insider Monkey

Harrow, Inc. (HROW): A Bull Case Theory  Insider Monkey

Harrow, Inc. (HROW): A Bull Case Theory - Insider Monkey

Click here to get full coverage on Harrow: Epic Growth & Operating Leverage On Full Display (NASDAQ:HROW) - Seeking Alpha

Harrow: Epic Growth & Operating Leverage On Full Display (NASDAQ:HROW)  Seeking Alpha

Harrow: Epic Growth & Operating Leverage On Full Display (NASDAQ:HROW) - Seeking Alpha

Click here to get full coverage on Harrow: Exciting Times In Store (NASDAQ:HROW) - Seeking Alpha

Harrow: Exciting Times In Store (NASDAQ:HROW)  Seeking Alpha

Harrow: Exciting Times In Store (NASDAQ:HROW) - Seeking Alpha

Click here to get full coverage on Analyst Updates Price Target for HROW to $69, Maintains Buy Rati - GuruFocus

Analyst Updates Price Target for HROW to $69, Maintains Buy Rati  GuruFocus

Analyst Updates Price Target for HROW to $69, Maintains Buy Rati - GuruFocus

Click here to get full coverage on New Analyst Forecast: $HROW Given $63.0 Price Target - Quiver Quantitative

New Analyst Forecast: $HROW Given $63.0 Price Target  Quiver Quantitative

New Analyst Forecast: $HROW Given $63.0 Price Target - Quiver Quantitative

Click here to get full coverage on HROW Investors Have Opportunity to Join Harrow, Inc. Fraud Investigation with the Schall Law Firm - PR Newswire

HROW Investors Have Opportunity to Join Harrow, Inc. Fraud Investigation with the Schall Law Firm  PR Newswire

HROW Investors Have Opportunity to Join Harrow, Inc. Fraud Investigation with the Schall Law Firm - PR Newswire

Click here to get full coverage on Harrow's Ambitious Guidance Puts It In The Proving Ground - Seeking Alpha

Harrow's Ambitious Guidance Puts It In The Proving Ground  Seeking Alpha

Harrow's Ambitious Guidance Puts It In The Proving Ground - Seeking Alpha

Click here to get full coverage on Harrow Health (HROW) Q3 Earnings Anticipation: Key Figures to Wa - GuruFocus

Harrow Health (HROW) Q3 Earnings Anticipation: Key Figures to Wa  GuruFocus

Harrow Health (HROW) Q3 Earnings Anticipation: Key Figures to Wa - GuruFocus

Click here to get full coverage on $HROW stock is down 12% today. Here's what we see in our data. - Quiver Quantitative

$HROW stock is down 12% today. Here's what we see in our data.  Quiver Quantitative

$HROW stock is down 12% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Decoding Harrow Inc (HROW): A Strategic SWOT Insight - GuruFocus

Decoding Harrow Inc (HROW): A Strategic SWOT Insight  GuruFocus

Decoding Harrow Inc (HROW): A Strategic SWOT Insight - GuruFocus

Click here to get full coverage on HROW: Can Strategic Moves Revive Investor Confidence? - timothysykes.com

HROW: Can Strategic Moves Revive Investor Confidence?  timothysykes.com

HROW: Can Strategic Moves Revive Investor Confidence? - timothysykes.com

Click here to get full coverage on Harrow: Immense Upside Potential (NASDAQ:HROW) - Seeking Alpha

Harrow: Immense Upside Potential (NASDAQ:HROW)  Seeking Alpha

Harrow: Immense Upside Potential (NASDAQ:HROW) - Seeking Alpha

Click here to get full coverage on Private Equity-Style Fund Buys $15.7 Million in Harrow Stock as Revenue Jumps 45% - The Motley Fool

Private Equity-Style Fund Buys $15.7 Million in Harrow Stock as Revenue Jumps 45%  The Motley Fool

Private Equity-Style Fund Buys $15.7 Million in Harrow Stock as Revenue Jumps 45% - The Motley Fool

Click here to get full coverage on Harrow, Inc. (NASDAQ:HROW) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Harrow, Inc. (NASDAQ:HROW) Receives Consensus Rating of "Moderate Buy" from Analysts  MarketBeat

Harrow, Inc. (NASDAQ:HROW) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Click here to get full coverage on Harrow, Inc. (NASDAQ:HROW) Looks Just Right With A 27% Price Jump - simplywall.st

Harrow, Inc. (NASDAQ:HROW) Looks Just Right With A 27% Price Jump  simplywall.st

Harrow, Inc. (NASDAQ:HROW) Looks Just Right With A 27% Price Jump - simplywall.st

Click here to get full coverage on Harrow Announces Pricing of $250.0 Million Offering of Senior Unsecured Notes Due 2030 - GlobeNewswire

Harrow Announces Pricing of $250.0 Million Offering of Senior Unsecured Notes Due 2030  GlobeNewswire

HROW

Price Chart

Key Statistics

Technicals

About HROW

Latest News

Brookstone Capital Management Grows Stock Holdings in Harrow, Inc. $HROW - MarketBeat

How CVS Elevating Vevye To Tier 1 Coverage At Harrow (HROW) Has Changed Its Investment Story - Yahoo Finance

First Week of February 2026 Options Trading For Harrow (HROW) - Nasdaq

Advanced Charts

Top Gainers

Top Losers